Frontiers in Molecular Biosciences (Apr 2024)

First insight about the ability of specific glycerophospholipids to discriminate non-small cell lung cancer subtypes

  • Julia Sieminska,
  • Katarzyna Miniewska,
  • Robert Mroz,
  • Ewa Sierko,
  • Wojciech Naumnik,
  • Joanna Kisluk,
  • Anna Michalska-Falkowska,
  • Joanna Reszec,
  • Miroslaw Kozlowski,
  • Lukasz Nowicki,
  • Marcin Moniuszko,
  • Marcin Moniuszko,
  • Adam Kretowski,
  • Adam Kretowski,
  • Jacek Niklinski,
  • Michal Ciborowski,
  • Joanna Godzien

DOI
https://doi.org/10.3389/fmolb.2024.1379631
Journal volume & issue
Vol. 11

Abstract

Read online

Introduction: Discrimination between adenocarcinoma (ADC) and squamous cell carcinoma (SCC) subtypes in non-small cell lung cancer (NSCLC) patients is a significant challenge in oncology. Lipidomics analysis provides a promising approach for this differentiation.Methods: In an accompanying paper, we explored oxPCs levels in a cohort of 200 NSCLC patients. In this research, we utilized liquid chromatography coupled with mass spectrometry (LC-MS) to analyze the lipidomics profile of matching tissue and plasma samples from 25 NSCLC patients, comprising 11 ADC and 14 SCC cases. This study builds upon our previous findings, which highlighted the elevation of oxidised phosphatidylcholines (oxPCs) in NSCLC patients.Results: We identified eight lipid biomarkers that effectively differentiate between ADC and SCC subtypes using an untargeted approach. Notably, we observed a significant increase in plasma LPA 20:4, LPA 18:1, and LPA 18:2 levels in the ADC group compared to the SCC group. Conversely, tumour PC 16:0/18:2, PC 16:0/4:0; CHO, and plasma PC 16:0/18:2; OH, PC 18:0/20:4; OH, PC 16:0/20:4; OOH levels were significantly higher in the ADC group.Discussion: Our study is the first to report that plasma LPA levels can distinguish between ADC and SCC patients in NSCLC, suggesting a potential role for LPAs in NSCLC subtyping. This finding warrants further investigation into the mechanisms underlying these differences and their clinical implications.

Keywords